Tangible pathologies in functional dyspepsia.
Atopy
Autoimmune
Dysbiosis
Dysmotility
Eosinophil
Functional dyspepsia
Genetics
Pathology
Therapy
Journal
Best practice & research. Clinical gastroenterology
ISSN: 1532-1916
Titre abrégé: Best Pract Res Clin Gastroenterol
Pays: Netherlands
ID NLM: 101120605
Informations de publication
Date de publication:
Historique:
received:
20
02
2019
revised:
05
08
2019
accepted:
12
08
2019
entrez:
10
10
2019
pubmed:
9
10
2019
medline:
4
12
2019
Statut:
ppublish
Résumé
Functional dyspepsia (FD) is a common, costly and complex disease, currently defined by symptoms, directed by the Rome consensus on functional bowel disorders, which has evolved over the past two decades. Symptoms include abdominal pain, are often meal related and there are two major subtypes, postprandial distress syndrome and epigastric pain syndrome, not attributed to pathology. Increasingly it is recognised that tangible pathologies occur in FD, for example Helicobacter pylori and other pathophysiological changes, most notably duodenal pathology, namely duodenal eosinophilia, permeability alterations, structural neuronal changes and microbial duodenal dysbiosis. This has led to the idea that FD is a true disease entity and triggers of this condition based on epidemiology studies point towards allergy, immune disorders and infection. Anxiety and depression may precede or follow FD, (brain-gut/gut-brain disorders). Currently most therapies for FD are inadequate but underlying pathology may lead to targeted treatment success as an attainable goal.
Identifiants
pubmed: 31594648
pii: S1521-6918(19)30053-8
doi: 10.1016/j.bpg.2019.101650
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101650Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.